Evidence map›Paper›PMID 40069299›Full record

ArticleCommunications biology2025

A large-scale benchmark for network inference from single-cell perturbation data.

Mathieu Chevalley, Yusuf H Roohani, Arash Mehrjou, Jure Leskovec, Patrick Schwab

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Causal graph neural networks for healthcare.Nature biomedical engineering · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Stochastic Modeling of Biophysical Responses to Perturbation.bioRxiv : the preprint server for biology · 2024
    Article
  18. AI approaches for the discovery and validation of drug targets.Cambridge prisms. Precision medicine · 2024
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mathieu ChevalleyGSK.ai, Zug, Switzerland.ORCID http://orcid.org/0009-0005-6339-6115
Yusuf H RoohaniGSK.ai, Zug, Switzerland.ORCID http://orcid.org/0000-0002-9577-5014
Arash MehrjouGSK.ai, Zug, Switzerland.ORCID http://orcid.org/0000-0002-3832-7784
Jure LeskovecStanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-5411-923X
Patrick SchwabGSK.ai, Zug, Switzerland. patrick.schwab@icloud.com.ORCID http://orcid.org/0000-0002-2868-7794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mapping biological mechanisms in cellular systems is a fundamental step in early-stage drug discovery that serves to generate hypotheses on what disease-relevant molecular targets may effectively be modulated by pharmacological interventions. With the advent of high-throughput methods for measuring single-cell gene expression under genetic perturbations, we now have effective means for generating evidence for causal gene-gene interactions at scale. However, evaluating the performance of network inference methods in real-world environments is challenging due to the lack of ground-truth knowledge. Moreover, traditional evaluations conducted on synthetic datasets do not reflect the performance in real-world systems. We thus introduce CausalBench, a benchmark suite revolutionizing network inference evaluation with real-world, large-scale single-cell perturbation data. CausalBench, distinct from existing benchmarks, offers biologically-motivated metrics and distribution-based interventional measures, providing a more realistic evaluation of network inference methods. An initial systematic evaluation of state-of-the-art causal inference methods using our CausalBench suite highlights how poor scalability of existing methods limits performance. Moreover, methods that use interventional information do not outperform those that only use observational data, contrary to what is observed on synthetic benchmarks. CausalBench subsequently enables the development of numerous promising methods through a community challenge, thus demonstrating its potential as a transformative tool in the field of computational biology, bridging the gap between theoretical innovation and practical application in drug discovery and disease understanding. Thus, CausalBench opens new avenues for method developers in causal network inference research, and provides to practitioners a principled and reliable way to track progress in network methods for real-world interventional data.

Indexed as

Computational BiologyGene Regulatory NetworksSingle-Cell AnalysisAlgorithmsBenchmarkingHumans

Identifiers

PMID40069299
PMCPMC11897147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.